Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT01876784
Title Evaluation of Efficacy, Safety of Vandetanib in Patients With Differentiated Thyroid Cancer
Recruitment Completed
Gender both
Phase Phase III
Variant Requirements No
Sponsors AstraZeneca
Age Groups: adult
Covered Countries USA | ITA | FRA | ESP

No variant requirements are available.